GLP-1 Without a Doctor Appointment: How Online Prescriptions Work in 2026
You don't need to see a doctor in person to get a GLP-1 prescription in 2026. This guide explains exactly how telehealth GLP-1 evaluation works, what it covers, and how to get started safely online.
Written by Trimi Medical Team. Medically reviewed by Trimi Medical Review Board. This article is for informational purposes only.
More on Access & Supply
Getting a GLP-1 prescription used to mean scheduling an appointment with your primary care provider or an obesity medicine specialist — often waiting weeks or months — and then navigating prior authorization before your medication arrived. In 2026, that process is no longer the only option.
Telehealth providers offer fully online GLP-1 evaluations where a board-certified provider reviews your health information and prescribes compounded semaglutide or tirzepatide — all without an in-person visit. This guide explains exactly how that process works, what providers are evaluating, what the limitations are, and how to verify that the telehealth provider you choose is operating safely and legally.
The Legal Basis for Telehealth GLP-1 Prescribing
Telehealth prescribing is legal in the United States under federal and state law frameworks that expanded significantly during the COVID-19 public health emergency (PHE) and were largely maintained afterward. The key points:
- Providers can establish a patient-provider relationship and prescribe non-controlled substances (including semaglutide and tirzepatide) via telehealth in most states
- Asynchronous telehealth — where the patient completes an assessment and the provider reviews it asynchronously, without a live video call — is permitted for non-controlled substance prescribing in most states
- Providers must be licensed in the state where the patient is located
- The same standard of care, record-keeping, and informed consent requirements apply to telehealth as to in-person visits
- Semaglutide and tirzepatide are non-controlled substances — they do not require the same prescribing restrictions as opioids or stimulants
Trimi's providers are licensed in the states where they practice and prescribe. The platform is designed to comply with each state's specific telehealth regulations.
How the Online GLP-1 Evaluation Works: Step by Step
Here is exactly what happens during a Trimi online evaluation — from first login to receiving your medication.
- 1
Health assessment (10 minutes)
You complete a structured online questionnaire covering: height and weight (for BMI calculation), complete medical history, current prescription and OTC medications, known allergies, weight-loss history and prior treatments, lifestyle information (activity level, diet habits), any prior GLP-1 use, and your specific goals. This information forms the clinical record your provider will review.
- 2
Provider review (within 24 hours)
A board-certified provider — typically an MD or NP specializing in obesity medicine, internal medicine, or family medicine — reviews your assessment. They evaluate clinical eligibility, check for contraindications, assess drug interactions, and determine appropriate starting dose. If they have clinical questions, they may follow up by message or request additional information before prescribing.
- 3
Prescription sent to pharmacy (if approved)
If you are clinically appropriate for GLP-1 treatment, the provider sends your prescription to Trimi's accredited compounding pharmacy. The prescription specifies medication type (semaglutide or tirzepatide), starting dose, titration schedule, and refill parameters.
- 4
Pharmacy preparation and shipping (2–3 business days)
The accredited compounding pharmacy prepares your medication, conducts batch quality testing, and ships via insulated cold-pack packaging to protect the semaglutide during transit. You receive tracking information.
- 5
Delivery and first injection (5–7 business days total)
Your package arrives with: multi-dose semaglutide vial, insulin syringes, alcohol wipes, dose-titration schedule, injection instructions, and provider contact information. Your first injection can be administered the day your package arrives.
What the Provider Is Actually Evaluating
Understanding what a telehealth provider looks at helps you understand what information to provide accurately. The evaluation covers:
Clinical eligibility criteria
- BMI ≥ 30 (obesity) OR BMI ≥ 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, hyperlipidemia, sleep apnea, or cardiovascular disease)
- No contraindications to GLP-1 receptor agonists
- Not pregnant or planning pregnancy
- Age 18 or older (programs for adolescents under 18 are handled separately per FDA labeling)
Contraindications and safety screens
- Personal or family history of medullary thyroid carcinoma (MTC) — absolute contraindication
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — absolute contraindication
- History of pancreatitis — caution, may be contraindicated depending on severity
- Severe gastrointestinal disease (gastroparesis) — typically contraindicated
- Known hypersensitivity to semaglutide or tirzepatide
- Current medication interactions — reviewed for drugs that affect gastric motility, insulin, or renal function
What Online Evaluations Cannot Replace
Telehealth GLP-1 prescribing is appropriate for most patients, but it is not a substitute for all in-person care. Being transparent about this matters.
Physical examination
Telehealth cannot perform a physical exam. If your provider has clinical questions that require physical assessment — abdominal tenderness, thyroid examination — an in-person visit may be needed before prescribing.
Real-time lab values
The initial prescription does not require labs for most patients. But if you have active type 2 diabetes, kidney disease, or other conditions where baseline labs matter for safety, your provider may request labs before or shortly after starting.
Complex comorbidity management
Patients with multiple complex conditions — particularly active cardiovascular disease, significant kidney disease, or complex diabetes management — may benefit from in-person specialist involvement alongside their telehealth GLP-1 program.
Why People Choose Telehealth Over In-Person for GLP-1s
The shift toward telehealth GLP-1 prescribing is driven by real-world access factors, not just convenience:
| Factor | Traditional In-Person | Telehealth (Trimi) |
|---|---|---|
| Wait time for appointment | 2–8 weeks for PCP, 3–6 months for obesity specialist | Assessment same day; provider review within 24 hrs |
| Time to first medication | Weeks to months (PA + prescription + pharmacy) | 5–10 business days |
| Monthly cost | Visit copay + PA + brand-name Rx cost | $99/month all-inclusive |
| Insurance required | For covered prescription; PA almost always required | No — cash-pay direct |
| Privacy | In-office, potentially less private | Completely private, at-home assessment |
| Geographic access | Requires nearby provider | Available in all 50 states |
How to Verify a Telehealth GLP-1 Provider Is Legitimate
The growth of telehealth GLP-1 prescribing has attracted both excellent providers and low-quality operations. Here is how to verify legitimacy:
- Medical evaluation required: Any legitimate provider requires a health assessment before prescribing. 'No questions asked' or instant approval programs are not practicing medicine.
- Named, verifiable pharmacy: The compounding pharmacy should be disclosed. Verify it in NABP's online lookup or the FDA's 503B database.
- Licensed providers disclosed: Your prescribing provider's name, credentials, and state license should be accessible.
- Ongoing provider access: A legitimate program includes provider contact for questions, dose adjustments, and side-effect management after the initial prescription.
- Transparent pricing: All costs should be disclosed upfront — no hidden fees, auto-charges, or unclear refund terms.
- Quality documentation available: Third-party batch testing certificates should be available on request.
Ongoing Care: What Happens After Your First Injection
The initial evaluation is the beginning of a clinical relationship, not a one-time transaction. Here is what ongoing care looks like through Trimi:
- Monthly refills at $99/month — medication ships automatically with confirmed provider approval
- Provider messaging available for questions about side effects, injection technique, or clinical concerns
- Dose adjustments: if side effects are significant or weight loss is insufficient, your provider can modify the titration
- Periodic check-in messages from the clinical team during the first 12 weeks
- Transition support: if you switch to brand-name coverage, your provider can coordinate the handoff
If you are concerned about access to care or continuity, read weight loss medication with no wait list and what happens if semaglutide doesn't work for you.
Common Concerns About Online GLP-1 Prescribing
"Is it really safe without a physical exam?"
For GLP-1 prescribing, the key safety screens are history-based — contraindications, drug interactions, and comorbidities are identified through a thorough questionnaire. The physical exam adds limited incremental safety for this specific prescribing decision. Medical boards in most states have determined that telehealth prescribing for non-controlled substances with these characteristics meets the standard of care.
"What if something goes wrong?"
Your Trimi provider is accessible by message for any clinical concern. For urgent side effects — severe abdominal pain suggesting pancreatitis, allergic reactions, significant hypoglycemia in diabetic patients — call 911 or go to an emergency room immediately and contact your Trimi provider afterward. These are the same instructions that would apply with a brand-name prescription from an in-person provider.
"Will my regular doctor know I'm on this?"
Your regular doctor does not automatically receive notification. We encourage patients to inform their primary care provider that they are taking semaglutide, as it affects other medications (particularly diabetes drugs) and is clinically relevant to their overall care. Trimi can provide clinical documentation for your records.
For patients whose doctor has actively declined to prescribe GLP-1 medications, see what to do when your doctor won't prescribe GLP-1.
Frequently Asked Questions
Can I get a GLP-1 prescription without seeing a doctor in person?
Yes. In 2026, telehealth providers like Trimi offer fully asynchronous online evaluations where a board-certified provider reviews your health history, medications, and weight-loss goals and — if clinically appropriate — prescribes compounded semaglutide or tirzepatide without an in-person appointment. This is legal in most U.S. states under telehealth regulations established during and after the COVID-19 public health emergency.
Is a telehealth GLP-1 evaluation as rigorous as an in-person evaluation?
A well-designed telehealth evaluation covers the same clinical criteria as an in-person evaluation: BMI, medical history, current medications, contraindications, and comorbidities. It does not include a physical exam. For GLP-1 prescribing, a physical exam is generally not required — the primary clinical criteria are documented weight, medical history, and absence of contraindications. Telehealth providers are licensed clinicians bound by the same standard of care as in-person providers.
How long does the online GLP-1 evaluation process take?
The patient-facing portion — completing the online health assessment — takes approximately 10 minutes. Provider review and a prescribing decision typically happen within 24 hours. Medication is shipped within 2–3 business days of approval and delivered within 5–7 business days. Total time from starting the assessment to receiving your first injection is typically 7–10 business days.
What questions does the online evaluation ask?
Trimi's health assessment covers: current height and weight, BMI calculation, medical history (diabetes, cardiovascular disease, thyroid conditions, pancreatitis, kidney disease), current medications (to screen for interactions), known allergies, weight-loss history, and current lifestyle information. You are also asked about any previous GLP-1 use. The provider reviews all responses before making a prescribing decision.
Are there conditions that disqualify me from getting a GLP-1 online?
Yes. GLP-1 medications are not appropriate for everyone. Absolute contraindications include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and known hypersensitivity to semaglutide. Providers also exercise caution with patients who have active pancreatitis, severe gastrointestinal disorders, or certain other conditions. These contraindications are screened during the online evaluation — patients with these conditions will not be prescribed GLP-1 medications through Trimi.
Do I need lab work or a physical before getting an online GLP-1 prescription?
Not necessarily for the initial prescription. Some providers request baseline labs (A1C, kidney function, lipid panel) for patients with specific conditions. For most otherwise healthy adults with obesity, the initial prescription does not require prior lab work. Your provider may recommend labs after you start treatment.
What ongoing support is included with a telehealth GLP-1 program?
Trimi's program includes ongoing provider access for dose adjustments, side-effect management, and clinical questions — not just the initial evaluation. Patients can message their provider, request dose changes, and receive clinical guidance throughout their treatment. Monthly refills include provider check-ins.
Related Reading
Sources & References
- FDA prescribing information for Wegovy (semaglutide injection 2.4mg).
- STEP 1 trial: Wilding JPH et al. Once-Weekly Semaglutide. NEJM 2021;384:989–1002.
- FDA guidance on pharmaceutical compounding.
- HHS telehealth guidance and HIPAA compliance for remote prescribing.
- NABP PCAB compounding pharmacy accreditation standards.
Medical Disclaimer: This content is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Telehealth evaluations are conducted by licensed healthcare providers — they do not replace your ongoing relationship with your primary care provider. Always inform your regular doctor about any new medications you start.